APA (7th ed.) Citation

J, F., G, S., A, M., R, G., M, H., V, S., . . . K, B. (2025). Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: A secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trial. The Lancet. Oncology, 26(8), 1081. https://doi.org/10.1016/S1470-2045(25)00262-1

Chicago Style (17th ed.) Citation

J, Ferdinandus, et al. "Fertility in Patients with Advanced-stage Classic Hodgkin Lymphoma Treated with BrECADD Versus EBEACOPP: A Secondary Analysis of the Multicentre, Randomised, Parallel, Open-label, Phase 3 HD21 Trial." The Lancet. Oncology 26, no. 8 (2025): 1081. https://doi.org/10.1016/S1470-2045(25)00262-1.

MLA (9th ed.) Citation

J, Ferdinandus, et al. "Fertility in Patients with Advanced-stage Classic Hodgkin Lymphoma Treated with BrECADD Versus EBEACOPP: A Secondary Analysis of the Multicentre, Randomised, Parallel, Open-label, Phase 3 HD21 Trial." The Lancet. Oncology, vol. 26, no. 8, 2025, p. 1081, https://doi.org/10.1016/S1470-2045(25)00262-1.